Inmed Pharmaceuticals (INM): Deep Track Capital, LP now owns 5.6% of INM as a passive investor 5.6%

5.6%

Stake · was 5.6%

2.98M

Shares owned

Stake as of

Nov 6, 2026

Filed

Nov 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 14, 2026Insider · 2 days before an 8-K10% owner purchased ~$37K of INM shares in the open market
2. Sep 15, 2026Insider · 1 day before an 8-K10% owner purchased ~$70K of INM shares in the open market
3. Sep 16, 2026Company filing · Form 8-K · Listing notice, Other newsReceived a notice from its stock exchange, and reported other company news“On September 16, 2026, InMed Pharmaceuticals Inc. (the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying it that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in shareholders’ equity for continued listing.”
4. Sep 16, 2026Insider10% owner purchased ~$11K of INM shares in the open market
5. Oct 1, 2026Insider10% owner purchased ~$22K of INM shares in the open market
6. Oct 2, 2026Insider10% owner purchased ~$11K of INM shares in the open market
7. Oct 5, 2026Insider10% owner purchased ~$24K of INM shares in the open market
8. Oct 6, 2026Insider10% owner purchased ~$7.4K of INM shares in the open market
9. Oct 7, 20265% stakeADAR1 Capital Management, LLC reported a passive stake (13G) of 17.2%
10. Oct 7, 2026Insider10% owner purchased ~$4.1K of INM shares in the open market
11. Oct 8, 2026Insider10% owner purchased ~$3K of INM shares in the open market
12. Oct 13, 2026Insider10% owner purchased ~$750 of INM shares in the open market
13. Oct 14, 2026Insider10% owner purchased ~$11K of INM shares in the open market
14. Oct 15, 2026Insider10% owner purchased ~$1.3K of INM shares in the open market
15. Oct 16, 2026Insider10% owner purchased ~$1 of INM shares in the open market
16. Oct 19, 2026Insider10% owner purchased ~$1.4K of INM shares in the open market
17. Oct 23, 2026Insider10% owner purchased ~$5 of INM shares in the open market
18. Nov 4, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote (and 1 more item)
19. Nov 5, 2026Insider · 5 days before results10% owner purchased ~$35K of INM shares in the open market

What came next

1. Nov 10, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and control of the company changed hands (and 8 more items)“On November 6, 2026, Eric A. Adams, John Bathery, Andrew Hull, Neil Klompas and Nicole Lemerond resigned from the Company’s board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company’s operations, policies or practices.”
2. Nov 12, 20265% stakeFairmount Funds Management LLC filed an activist stake (13D) of 20.0%
3. Nov 13, 20265% stakeDeep Track Capital, LP reported a passive stake (13G) of 5.6%
4. Nov 13, 20265% stakeCommodore Capital LP reported a passive stake (13G) of 5.6%

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Inmed Pharmaceuticals

For Inmed Pharmaceuticals, OQRO holds 16 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INM page.

How this filing works

• Schedule 13D vs 13G

Other disclosures at Inmed Pharmaceuticals

• SEC Schedule 13GNov 13, 2026
• SEC Schedule 13DNov 12, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 4Oct 27, 2026
• SEC Form 4Oct 20, 2026
• SEC Form 4Oct 20, 2026

Everything OQRO holds on this company is on its INM page.